No Data
No Data
B.Riley Financial Maintains LifeMD(LFMD.US) With Buy Rating, Cuts Target Price to $11
Craig-Hallum Maintains LifeMD(LFMD.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: Ginkgo Bioworks Holdings (DNA) and LifeMD (LFMD)
Take Care Before Jumping Onto LifeMD, Inc. (NASDAQ:LFMD) Even Though It's 27% Cheaper
Analyst Estimates: Here's What Brokers Think Of LifeMD, Inc. (NASDAQ:LFMD) After Its Second-Quarter Report
Express News | Cantor Fitzgerald Reiterates Overweight on LifeMD, Maintains $15 Price Target
No Data